Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Introduction To Survival Analysis

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...

Actuarial Approach

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Analysis on trends of mortality rate and disease burden of liver cancer in Tianjin, China from 1999 to 2021].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2024

Same author

[Clinical distribution and drug resistance characteristics of carbapenem-resistant <i>Klebsiella pneumoniae</i>].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2023

Same author

[Study on increase of average life expectancy of residents in Tianjin from 1999 to 2018].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2021

Same author

[Analysis on long-term trend of mortality and years of life lost of breast cancer in women in Tianjin, 1999-2017].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2020

Same author

[Analysis on the alterative trend of colorectal cancer mortality from 1999 to 2015 in Tianjin of China].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery·2019

Same author

[Analysis on trend of leukemia mortality from 1999 to 2015 in Tianjin, China].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2019

Search research articles

Related Experiment Video

Updated: Jun 28, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

[Cancer survival analysis in Tianjin, 2010 to 2016].

C Wang¹, C F Shen¹, L N Xun¹

¹Department of Cancer Registration, Institution of Noncommunicable Disease Prevention and Control, Tianjin Center for Disease Control and Prevention, Tianjin 300011, China.

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]

|April 21, 2024

Summary

Cancer survival rates in Tianjin significantly increased from 2010-2016, showing improved prevention and treatment effectiveness. Focus remains on males, rural populations, older individuals, and specific cancers like lung and liver cancer.

More Related Videos

Analysis of Side Population in Solid Tumor Cell Lines

Analysis of Side Population in Solid Tumor Cell Lines

Published on: February 23, 2021

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

Related Experiment Videos

Last Updated: Jun 28, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Analysis of Side Population in Solid Tumor Cell Lines

Analysis of Side Population in Solid Tumor Cell Lines

Published on: February 23, 2021

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

Area of Science:

Oncology
Public Health
Epidemiology

Context:

Cancer incidence and survival data from Tianjin, China, between 2010 and 2016.
Follow-up data extended to December 31, 2021.
Analysis aimed to inform regional health policies.

Purpose:

To conduct a survival analysis of cancer incidence in Tianjin.
To provide a basis for formulating and evaluating regional health policies.
To identify trends and disparities in cancer survival rates.

Summary:

The 5-year relative survival rate for cancer in Tianjin increased from 41.92% to 53.65% between 2010-2016, averaging 48.56%.
Survival rates were higher for females (57.71%) than males (39.20%) and urban (49.38%) than rural residents (47.24%).
Median survival times also showed an increasing trend, with significant variations across age groups and genders.

Impact:

The study indicates a significant improvement in cancer prevention and treatment effectiveness in Tianjin.
Highlights the need for targeted interventions for male, rural, and elderly populations.
Recommends specific focus on lung, esophagus, liver, gallbladder, and pancreatic cancers.